Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 8293

Circa 2011

Most bacterial infections can be treated with antibiotics such as penicillin, discovered decades ago. However, such drugs are useless against viral infections, including influenza, the common cold, and deadly hemorrhagic fevers such as Ebola.

Now, in a development that could transform how viral infections are treated, a team of researchers at MIT’s Lincoln Laboratory has designed a drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection.

Continue reading “New drug could cure nearly any viral infection” | >

Do you agree.

In addition, gene-editing technologies continue to advance in precision and ease of use, allowing families to treat and ultimately cure hundreds of inheritable genetic diseases.

This metatrend is driven by the convergence of: various biotechnologies (CRISPR, Gene Therapy), genome sequencing, and artificial intelligence.

Read more | >

Facebook has built a tool called Getafix that automatically finds fixes for bugs and offers them to engineers to approve. This allows engineers to work more effectively, and it promotes better overall code quality. We believe Getafix is the first tool of its kind to be deployed to production at Facebook scale, contributing to the …

Read more | >

A system for transmission of information using a curl-free magnetic vector potential radiation field. The system includes current-carrying apparatus for generating a predominantly curl-free magnetic vector potential field coupled to apparatus for modulating the current applied to the field generating apparatus. Receiving apparatus includes a detector with observable properties that vary with the application of an applied curl-free magnetic vector potential field. Analyzing apparatus for determining the information content of modulation imposed on the curl-free vector potential field is coupled to the detector. The magnetic vector potential field can be established in materials that are not capable of transmitting more common electromagnetic radiation.

The receiver may detect changes of phase of the sine function which determines the Josephson junction current. The distance of the transmitter can be determined from the strength of the received signal. By generating a field of predetermined orientation and using a detector responsive to orientation, the direction of the transmitter may be determined. A rotating field may be used for this.

Read more | >

A Cambridge-based biotech company that is creating a colony of “human” mice is locked in a Tom and Jerry-style fight with a US pharmaceutical giant.

Kymab, which is backed by the Bill and Melinda Gates Foundation and counts fund manager Neil Woodford among its investors, is seeking permission to appeal to the Supreme Court in a row over patents. It follows a ruling by the Court of Appeal earlier this year that Kymab infringed a patent belonging to US company Regeneron. A previous judgment ruled that Regeneron’s patent was insufficient.

The legal tussle relates to Kymab’s “Kymouse” work, in which it manipulates the genome of mice. Kymab removes the genes that make antibodies in mice and replaces them with human antibody genes. This means that.

Read more | >